Dr. Reddy's Laboratories is a global, vertically integrated pharmaceutical company with a presence across the value chain through its various businesses, including PSAI (Pharmaceutical Services & Active Ingredients), Global Generics and Proprietary Products (NCEs, Biosimilars & Differentiated Formulations). The company's products are marketed with emphasis on North America, Europe, India, Russia while building presence in several other markets. Improving affordability of pharmaceutical products globally, creating innovation driven businesses for long term value and embracing the triple bottom line approach to sustainability define us.

Acquired Companies: Dowpharma, Trigenesis Therapeutics, Inc.